ICON shares are trading higher after the company announced a multi-year collaboration with Anthropic to bring Claude’s AI capabilities across the clinical trial lifecycle.

Benzinga Newsdesk www.benzinga.com Positive 95.1%

Neg 0% Neu 0% Pos 95.1%

Comments

No comments yet. Be the first!